← back to search

Chunlin Chen

Dalian Medical University · CN
Area of research
Obstetrics and Gynecology · Epidemiology
Research interest
Research focused on Cervical cancer and Stage (stratigraphy), with related work in Adenomyosis, TFAM, Radical Hysterectomy. Notable publications include 'Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn’s Disease: Results From the VISIBLE 2 Randomised Trial', 'Outcomes in Adenomyosis Treated with Uterine Artery Embolization Are Associated with Lesion Vascularity: A Long-Term Follow-Up Study of 252 Cases', and 'The pathological risk score: A new deep learning‐based signature for predicting survival in cervical cancer'.
h-index
citations
446
works
28
NIH funding
primary concept
email

Recent publications

Comparison of oncological outcomes between radical hysterectomy and radiochemotherapy for International Federation of Gynecology and Obstetrics 2018 stage <scp>IIIC1</scp> cervical adenocarcinoma: A retrospective multicenter cohort study
Journal of obstetrics and gynaecology research 2025cited by 1position: middledoi
Perineural invasion in cervical cancer: A multicenter retrospective study
European Journal of Surgical Oncology 2024cited by 13position: lastdoi
Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma
European Journal of Surgical Oncology 2024cited by 5position: lastdoi
Impact of different postoperative adjuvant therapies on the survival of early‐stage cervical cancer patients with one intermediate‐risk factor: A multicenter study of 14 years
Journal of obstetrics and gynaecology research 2023cited by 13position: lastdoi
Rationality of <scp>FIGO</scp> 2018 <scp>IIIC</scp> restaging of cervical cancer according to local tumor size: A cohort study
Acta Obstetricia Et Gynecologica Scandinavica 2023cited by 13position: lastdoi
Risk factors for and delayed recognition of genitourinary fistula following radical hysterectomy for cervical cancer: a population-based analysis
Journal of Gynecologic Oncology 2023cited by 10position: lastdoi
Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors
BMC Cancer 2023cited by 8position: lastdoi
Which factors predict parametrial involvement in stage IB cervical cancer? A Chinese multicentre study
European Journal of Surgical Oncology 2023cited by 4position: lastdoi
Laparoscopic versus open radical hysterectomy in <scp>FIGO</scp> 2018 early‐stage cervical adenocarcinoma: Long‐term survival outcomes after propensity score matching
Journal of obstetrics and gynaecology research 2023cited by 2position: lastdoi
Comparison of surgical and radio-chemotherapy oncology outcomes for cervical adenocarcinoma FIGO2018 stage Ⅱ B
Research Square 2023cited by 0position: middledoi
Comparison between laparoscopic and abdominal radical hysterectomy for cervical adenosquamous carcinoma at stage <scp>IA2</scp> to <scp>IIA2</scp>: A multicenter retrospective study
Journal of obstetrics and gynaecology research 2023cited by 0position: lastdoi
Abdominal Radical Hysterectomy as an Alternative Treatment Option for Patients with Cervical Cancer without Access to Radiotherapy Facilities
Clinical and Experimental Obstetrics & Gynecology 2023cited by 0position: lastdoi
The pathological risk score: A new deep learning‐based signature for predicting survival in cervical cancer
Cancer Medicine 2022cited by 37position: middledoi
Comparison of survival outcomes between squamous cell carcinoma and adenocarcinoma/adenosquamous carcinoma of the cervix after radical radiotherapy and chemotherapy
BMC Cancer 2022cited by 25position: lastdoi
Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study
Annals of Translational Medicine 2022cited by 15position: lastdoi
Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study
Annals of Translational Medicine 2022cited by 6position: lastdoi
Survival Outcomes of Patients With Stage IB3 Cervical Cancer Who Undergo Abdominal Radical Hysterectomy Versus Radiochemotherapy
Frontiers in Oncology 2022cited by 3position: lastdoi
Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn’s Disease: Results From the VISIBLE 2 Randomised Trial
Journal of Crohn s and Colitis 2021cited by 168position: middledoi
VEGFR2 inhibition hampers breast cancer cell proliferation &lt;i&gt;via&lt;/i&gt; enhanced mitochondrial biogenesis
Cancer Biology and Medicine 2021cited by 35position: middledoi
Cohort Profile: Chinese Cervical Cancer Clinical Study
Frontiers in Oncology 2021cited by 13position: lastdoi
Comparison of survival outcomes with or without Para-aortic lymphadenectomy in surgical patients with stage IB1-IIA2 cervical cancer in China from 2004 to 2016
BMC Cancer 2021cited by 11position: firstdoi
Uterine corpus invasion in cervical cancer: a multicenter retrospective case–control study
Archives of Gynecology and Obstetrics 2021cited by 10position: lastdoi
Effects of ginsenoside Rb1 on serum brain natriuretic peptide level and caspase-3 protein expression in cardiomyocytes of rats with chronic heart failure
Pharmacognosy Magazine 2021cited by 3position: lastdoi
The Effect of Laparoscopic Radical Hysterectomy Surgical Volume on Oncology Outcomes in Early-Stage Cervical Cancer
Frontiers in Surgery 2021cited by 1position: lastdoi
Comparison of survival outcomes of abdominal radical hysterectomy and radiochemotherapy IIA2 (FIGO2018) cervical cancer: a retrospective study from a large database of 63,926 cases of cervical cancer in China
International Journal of Clinical Oncology 2021cited by 1position: lastdoi
Comparison of Survival Outcomes with or Without Para-aortic Lymphadenectomy in Surgical Patients with Stage IB1-IIA2 Cervical Cancer in China from 2004-2016
Research Square 2021cited by 0position: firstdoi
Laparoscopic versus abdominal radical hysterectomy for stage IB1 cervical cancer patients with tumor size ≤ 2 cm: a case-matched control study
International Journal of Clinical Oncology 2020cited by 33position: firstdoi
Comparison between laparoscopic and abdominal radical hysterectomy for stage IB1 and tumor size &lt;2 cm cervical cancer with visible or invisible tumors: a multicentre retrospective study
Journal of Gynecologic Oncology 2020cited by 31position: lastdoi
Influence of uterine corpus invasion on prognosis in stage IA2–IIB cervical cancer: A multicenter retrospective cohort study
Gynecologic Oncology 2020cited by 17position: lastdoi
Comparison of laparoscopic and abdominal radical hysterectomy for early stage cervical cancer: oncologic outcomes based on tumor diameter
International Journal of Gynecological Cancer 2020cited by 15position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Ping Liu · Ministry of Education of the People's Republic of China25 papers (2016–2025)Shan Kang · Qingdao University20 papers (2019–2024)Weili Li · Hospital for Sick Children14 papers (2016–2023)Xiaonong Bin · Guangzhou Medical University13 papers (2020–2023)Jinghe Lang · Chinese Academy of Medical Sciences & Peking Union Medical College13 papers (2020–2023)Pengfei Li · Sun Yat-sen University Cancer Center11 papers (2020–2023)Hui Duan · Southern Medical University9 papers (2016–2024)Yan Ni · Xiamen University8 papers (2019–2021)Min Hao · Shanxi Medical University8 papers (2019–2023)Li Wang · Hebei Medical University8 papers (2020–2023)Donglin Li · Nanchang University7 papers (2020–2023) · 7 papers (2021–2023)Zhiqiang Li · Nanchang University7 papers (2020–2023)Xiaolin Chen · Beijing Tian Tan Hospital7 papers (2019–2024) · 6 papers (2020–2022)Weidong Zhao · Anhui Medical University6 papers (2019–2023)Lihong Lin · Wenzhou Medical University5 papers (2021–2023)Mei Ji · Parker Institute for Cancer Immunotherapy5 papers (2021–2023)Bin Ling · Anhui Medical University5 papers (2019–2023)Huijian Fan · Southern Medical University5 papers (2020–2023)